| PACIRA BIOSCIENC. DL-,001 |
| USA |
| Gesundheit |
| US6951271005 / A1H68T |
| 82P (Frankfurt) / PCRX (NASDAQ) |
| FRA:82P, ETR:82P, 82P:GR, NASDAQ:PCRX |
| - |
| http://www.pacira.com/ |
|
Pacira BioSciences, Inc. is a specialty biopharmaceutical company focused on non-opioid pain management and regenerative health solutions. Pacira BioSciences develops, manufactures, markets, distributes, and sells therapies used across postsurgical, ..
>Volltext.. |
| 876.77 Mio. EUR |
| 1019.86 Mio. EUR |
| 662.84 Mio. EUR |
| 100.19 Mio. EUR |
| 13 Mio. EUR |
| 0.31 EUR |
| 366.1 Mio. EUR |
| 182.89 Mio. EUR |
| 166.71 Mio. EUR |
| 2.06 |
| 5.71% |
| - |
| - |
| - |
| - |
| - |
| PACIRA |
| 08.10.26 |
|
||||
|